Abstract
Fibroblast growth factors (FGFs) stimulate the proliferation of a variety of cells and protect against stress-induced apoptosis. We have demonstrated that basic FGF (bFGF) significantly stimulates intestinal cell proliferation and protects against dexamethasone-induced apoptosis. In this study, we further investigate the effects of bFGF on radiation-induced inhibition of thymocyte and splenocyte proliferation and apoptotic cell death. Mice were subjected to whole-body X-rays irradiation by at a dose of 0.5 Gy or 1.0 Gy and 14 hr later thymocytes and splenocytes were collected for in vitro culture with or without bFGF. Radiation induced a significant decrease in the cell proliferation of both thymocytes and splenocytes, which was not significantly inhibited by incubation with bFGF. Radiation with 0.5 and 1.0 Gy also significantly increased apoptotic cell death in both thymocytes and splenocytes, and incubation with bFGF did not significantly affect the apoptotic effects of radiation. These results suggest that incubation of bFGF in vitro with thymocytes and splenocytes from irradiated mice did not significantly prevent radiation-induced inhibition of cell proliferation and apoptotic effects.
Introduction
Ionizing radiation is a vital tool in cancer therapy but causes significant collateral damage to healthy tissues, particularly the immune system. The thymus and spleen are highly sensitive to radiation, which triggers cell death (apoptosis) and halts cell division (proliferation inhibition), leading to immunosuppression. Previous research showed that basic Fibroblast Growth Factor (bFGF)—a protein that stimulates cell growth—could protect intestinal and skin cells from radiation and chemical stress. This study sought to determine if bFGF could offer the same protection to immune cells.
Methods
The researchers used a hybrid in vivo/in vitro approach. Adult male Kunming mice were subjected to whole-body X-ray radiation at doses of 0.5 Gy or 1.0 Gy. Fourteen hours after irradiation, thymocytes and splenocytes were harvested and cultured in vitro with varying concentrations of bFGF (0.25 to 2.0 µg/ml). Proliferation was measured by $[^3H]$-TdR incorporation, and apoptosis was quantified using flow cytometry with Propidium Iodide (PI) staining and confirmed via DNA fragmentation analysis.
Key Results
Proliferation Inhibition
Exposure to 0.5 and 1.0 Gy significantly inhibited cell proliferation in a dose-dependent manner. As shown in Figure 1, $[^3H]$-TdR incorporation was markedly reduced in irradiated cells. Adding bFGF (up to 0.5 µg/ml) did not significantly improve the proliferation rate of either cell type after radiation, suggesting that the growth factor could not rescue the cells from radiation-induced arrest.
Apoptotic Cell Death
Radiation significantly increased apoptotic cell death in both thymocytes and splenocytes. Even when the dose of bFGF was increased to 2.0 µg/ml, it failed to significantly reduce the percentage of apoptotic cells across various incubation times (Figure 3). A very slight, statistically insignificant trend toward protection was noted in thymocytes at the highest bFGF dose after 8 hours of incubation, but it was insufficient to suggest a therapeutic benefit.
Discussion
The study found that by the time cells were harvested (14 hours post-irradiation), the damage was already established. Adding bFGF at this stage could not reverse the apoptotic signaling already in motion. These findings suggest that biological protection is not universal; a molecule that saves intestinal cells might be ineffective for lymphocytes. The authors hypothesize that bFGF might require the complex signaling environment of a living body (in vivo) to work, or perhaps it needs to be present at the moment of radiation to be effective. Future work should investigate prophylactic administration or in vivo treatment models.
Summary updated